REG - Carclo plc - Wipac Update

CarcloAnnouncement

23/08/2019 12:05

RNS Number : 0935K
Carclo plc
23 August 2019
 


23 August 2019
Carclo plc
 
    Wipac Update
 
Carclo plc ("Carclo" or the "Group"), a global manufacturer of fine tolerance injection moulded plastic parts mainly for the medical, automotive lighting and optics markets, announces the disposal of an asset of the Wipac business.
As part of the previously announced strategy to refocus Wipac (the "Company") back on its historic low-volume high-end vehicle markets, certain mid-volume programmes are being moved by customers to alternative suppliers. In respect to one of these moves, a specialist assembly line has been acquired by the associated customer. The customer paid £1.4m directly to a finance lease company for the elements of the line owned by them and £1.1m to Wipac for those elements of the line owned by the Company. A £0.4m loss was recorded on the sale.
Separately, a payment of Euro 3.4m was received in respect of outstanding design and development balances.
Discussions remain ongoing regarding a potential sale of the Wipac business.
 
Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.
 



Enquiries:


















Carclo plc                                                          01924 268040








Mark Rollins - Executive Chairman
Sarah Matthews-DeMers - Finance Director
 
FTI Consulting                                                  020 3727 1340

Nick Hasell / Susanne Yule           
 







 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISCKNDKDBKDDFB